University of Kansas Cancer Center Post San Antonio Review
Challenging Cases of BC: What Should Be the Next Line of Therapy for a Woman With HR+ mBC Who Received 1L ET + CDK4/6i? Should You Extend ET Beyond 5 Yrs for T2N0 HR+ Grade II IDC?
Comments 0
Login to view comments.
Click here to Login
